![]() Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Montreal Cognitive Assessment (MoCA) is one of the most widely used cognitive screening tests in primary and secondary care globally. (2005) 'The Montreal Cognitive Assessment, MoCA: a Brief Screening Tool for Mild Cognitive Impairment. Available from: ĭeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. The screening tool MoCA is superior to MMSE in the identification of MCI, and both tests were found to be accurate in the detection of AD. Montreal Cognitive Assessment (MoCA) Nasreddine Z. No effective screening test exists for detection of early or mild cognitive impairment in PD. ![]() Chronic organ failure in adult sickle cell disease. Cognitive impairment is common in Parkinsons disease (PD) and can occur early in the disease course. Cerebrovascular reserve capacity is impaired in patients with sickle cell disease. Nur E, Kim YS, Truijen J, van Beers EJ, Davis SCAT, Brandjes DP, Biemond BJ, van Lieshout JJ. Currently, there are a number of readily available screening instruments from which to choose. It is important to critically evaluate screening tools to ensure they are psychometrically valid. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene‐Frempong K, Krishnamurti L, et al. CRITICAL EVALUATION OF SCREENING INSTRUMENTS. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. Montreal Cognitive Assessment cognitive performance cognitive screening health literacy sickle cell disease. Here, we investigated whether results generated by the OCS vs the domain-general Montreal Cognitive Assessment (MoCA) at baseline impacted patient outcomes at 6 months follow-up. The MoCA is a promising option for briefly screening for cognitive impairment in adults with SCD, though further study is needed to confirm its validity. This pilot study adds to the limited literature of cognitive screening tests in adults with SCD and demonstrates a relationship between MoCA scores and measures of literacy and health literacy. ![]() In multivariable models, MoCA scores were associated with S-TOFHLA (p = 0.001) and WRAT-4 Reading (p = 0.002) scores, and overt stroke (p = 0.03) at the median. Higher educational attainment was associated with MoCA scores (p = 0.001). Among our sample of 49 adults with SCD, the median MoCA score was 25.0. Spearman's rho, Mann-Whitney, and Kruskal-Wallis tests and quantile regression models were used. We administered the MoCA a literacy test, the Wide Range Achievement Test, fourth edition (WRAT-4) and a health literacy test, the Shortened Test of Functional Health Literacy in Adults (S-TOFHLA) to adults with SCD and gathered clinical variables through chart review. We explored the Montreal Cognitive Assessment (MoCA) as a possible screening test in SCD. Guidelines support routine cognitive screening, but no screening test is validated in this population. Appropriate cutoffs and point adjustments for education are suggested.Ĭross-cultural Montreal Cognitive Assessment dementia mild cognitive impairment.Adults with sickle cell disease (SCD) are at risk for cognitive impairment, which causes significant morbidity. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. The review highlights the necessity for cross-cultural considerations when using the MoCA, and recognizing it as a screen and not a diagnostic tool. The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild cognitive dysfunction. Poor methodological rigor appears to have affected reported accuracy and validity of the MoCA. The results showed a wide range in suggested cutoffs for MCI cross-culturally, with variability in levels of sensitivity and specificity ranging from low to high. ![]() Quality ratings, forest plots of validated studies (sensitivity and specificity) with covariates (suggested cut-offs, age, education and country), and summary receiver operating characteristic curve are presented. The Montreal Cognitive Assessment (MoCA) is a cognitive screening instrument developed to detect mild cognitive impairment (MCI). The subject of the review assumes heterogeneity and therefore meta-analyses was not conducted. ![]() In addition, we report findings for differentiating dementias from NC and MCI from dementias, however, these were not considered to be an appropriate use of the MoCA. This review sourced a wide range of studies including case-control studies. We aimed to interrogate the validity of the MoCA in a cross-cultural context: in differentiating MCI from normal controls (NC) and identifying cut-offs and adjustments for age and education where possible. While there are many available versions, the cross-cultural validity of the assessment has not been explored sufficiently. The Montreal Cognitive Assessment (MoCA) is widely used to screen for mild cognitive impairment (MCI). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |